Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001415889-25-001163

Options or other derivatives

  • Director acquired 30,282 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Bray June Director 2025-01-02 Grant or award · Director Stock Option (right to buy) +30,282 30,282 D
Loading xslF345X05/form4-01092025_120106.xml…